Thursday, 18 Aug 2011 08:00pm EDT

Shenzhen Hepalink Pharma. Co., Ltd. (002399.SZ )announced that it will invest RMB 20 million to set up a joint venture with Dr. Liu Liping, with each to hold a 57.143% and a 42.857% stake. The joint venture will be with a registered capital of RMB 35 million and be engaged in the research and development of polypeptide drugs.